Antimicrobial therapy of community-acquired pneumonia
Thomas M File1, Michael S Niederman
1Summa Health System, 75 Arch Street, Suite 105, Akron, OH 44304, USA. filet@summa-health.org
Abstract:
Community-acquired pneumonia (CAP) is a common disorder that is potentially life-threatening, especially in older adults and patients with comorbid disease. Despite substantial progress in therapeutic options, CAP remains a primary cause of death from infectious disease in the United States. The mainstay of treatment for most patients is appropriate antimicrobial therapy This article reviews the principles for initial antimicrobial therapy, highlights some of the differences in approaches to antimicrobial drug selection in selected guidelines, and includes new recommendations for empiric and pathogen-directed therapy of CAP.
Insights
Community-acquired pneumonia (CAP) is a serious infection, particularly in older adults. This review covers current antimicrobial therapy principles and new recommendations for treating CAP effectively.
Area of Science:
- Infectious Diseases
- Pulmonology
- Pharmacology
Background:
- Community-acquired pneumonia (CAP) is a significant cause of mortality from infectious diseases in the US.
- CAP poses a particular threat to older adults and individuals with comorbidities.
- Despite advances, effective antimicrobial therapy remains crucial for managing CAP.
Purpose of the Study:
- To review the foundational principles of initial antimicrobial therapy for CAP.
- To highlight variations in antimicrobial drug selection strategies across different guidelines.
- To present updated recommendations for both empiric and pathogen-directed CAP treatment.
Main Methods:
- Literature review of current guidelines and therapeutic options for CAP.
- Analysis of principles for initiating antimicrobial treatment.
- Synthesis of new recommendations for empiric and targeted antimicrobial therapy.
Main Results:
- Antimicrobial therapy is the cornerstone of CAP management.
- Guideline recommendations for drug selection show some divergence.
- New evidence supports updated empiric and pathogen-directed treatment approaches.
Conclusions:
- Appropriate antimicrobial selection and timely administration are critical for CAP outcomes.
- Understanding guideline differences aids in optimizing treatment strategies.
- Adherence to updated recommendations can improve patient care and reduce mortality from CAP.
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:14Atypical Pneumonia
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:30Pneumonia III: Complications and Assessment
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...